▲ 0.42%
prev close
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.
Congressional Trades
11
All tracked trades
Members Trading
8
Unique members
Net Activity
-3
4 buys · 7 sells
Members Who Traded This Stock
11 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2026-01-09 | KVUEKenvue Inc. | Sell | $1,001 - $15,000 | 159d ago | — | |
| 2025-10-31 | KVUEKenvue Inc. | Sell | $1,001 - $15,000 | 243d ago | — | |
| 2025-10-30 | KVUEKenvue Inc. | Sell | $1,001 - $15,000 | 243d ago | — | |
| 2025-09-25 | KVUEKenvue Inc. | Buy | $1,001 - $15,000 | 273d ago | — | |
| 2025-09-23 | KVUEKenvue Inc. | Sell | $1,001 - $15,000 | 285d ago | — | |
| 2025-08-28 | KVUEKenvue Inc. | Sell | $1,001 - $15,000 | 322d ago | — | |
| 2025-06-16 | KVUEKenvue Inc. | Sell | $1,001 - $15,000 | 373d ago | — | |
| 2024-10-29 | KVUEKenvue Inc. | Buy | $1,001 - $15,000 | 313d ago | — | |
| 2024-10-23 | KVUEKenvue Inc. | Buy | $1,001 - $15,000 | 190d ago | — | |
| 2024-08-06 | KVUEKenvue Inc. | Sell | $1,001 - $15,000 | 701d ago | — | |
| 2023-08-03 | KVUEKenvue Inc. | Buy | $1,001 - $15,000 | 1061d ago | — |
2026-01-09
Gilbert Cisneros
KVUE
Amount
$1,001 - $15,000
Filed
159d ago
2025-10-31
Lisa McClain
KVUE
Amount
$1,001 - $15,000
Filed
243d ago
2025-10-30
Lisa McClain
KVUE
Amount
$1,001 - $15,000
Filed
243d ago
2025-09-25
Lisa McClain
KVUE
Amount
$1,001 - $15,000
Filed
273d ago
2025-09-23
Valerie Hoyle
KVUE
Amount
$1,001 - $15,000
Filed
285d ago
2025-08-28
Sheldon Whitehouse
KVUE
Amount
$1,001 - $15,000
Filed
322d ago
2025-06-16
Scott Scott Franklin
KVUE
Amount
$1,001 - $15,000
Filed
373d ago
2024-10-29
Valerie Hoyle
KVUE
Amount
$1,001 - $15,000
Filed
313d ago
2024-10-23
Julia Letlow
KVUE
Amount
$1,001 - $15,000
Filed
190d ago
2024-08-06
C. Scott Franklin
KVUE
Amount
$1,001 - $15,000
Filed
701d ago
2023-08-03
Lois Frankel
KVUE
Amount
$1,001 - $15,000
Filed
1061d ago
Recent News
Powered by Polygon.io
Is It Too Late to Buy Johnson & Johnson After Its Blowout Earnings Report?
Billionaire Ken Griffin Boosted His Stake in This Dividend King by 146%. Here's Why It's a Dream Stock for Risk-Averse Investors.
Church & Dwight vs. Kimberly-Clark: Which Consumer Goods Stock Is a Better Buy in 2026?
This 4.5%-Yielding Dividend Stock Is Beating the S&P 500 and the Nasdaq. 3 Reasons That Can Continue in the Second Half of 2026
Meet the Dividend King Stock That's Up 20% in 2026. Here's Why It Can Continue Outperforming the S&P 500 and Nasdaq-100 in the Second Half.
Trade Timeline
Congressional activity, newest first
Gilbert Cisneros
2026-01-09 · Sale
$1,001 - $15,000
Lisa McClain
2025-10-31 · Sale
$1,001 - $15,000
Lisa McClain
2025-10-30 · Sale
$1,001 - $15,000
Lisa McClain
2025-09-25 · Purchase
$1,001 - $15,000
Valerie Hoyle
2025-09-23 · Sale
$1,001 - $15,000
Sheldon Whitehouse
2025-08-28 · Sale
$1,001 - $15,000
Scott Scott Franklin
2025-06-16 · Sale
$1,001 - $15,000
Valerie Hoyle
2024-10-29 · Purchase
$1,001 - $15,000
Julia Letlow
2024-10-23 · Purchase
$1,001 - $15,000
C. Scott Franklin
2024-08-06 · Sale
$1,001 - $15,000
Lois Frankel
2023-08-03 · Purchase
$1,001 - $15,000